Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Recardio

Recardio?uq=hBqTzBbB
2011 FOUNDED
PRIVATE STATUS
Series A1 LATEST DEAL TYPE
$8M LATEST DEAL AMOUNT
4 INVESTORS
Description

Owner and operator of a life science company. The company focuses on developing regenerative therapeutic modalities for the treatment of cardiovascular diseases.

Website
Ownership Status
Privately Held (backing)
Financing Status
Angel-Backed
Primary Industry
Biotechnology
Primary Office
  • 1 Market Street
  • Spear Tower, 36th
  • San Francisco, CA 94105
  • United States
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Recardio’s full profile, request a free trial.

Recardio Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Angel (individual) 30-Aug-2016 $8M 000.00 0000 Completed Generating Revenue
3. Angel (individual) 11-Nov-2015 000 00.000 0000 Completed Startup
2. Grant 25-Mar-2014 $1.38M $1.29M Completed Startup
1. Seed Round 01-Jan-2012 $1.29M $1.29M Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Recardio Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned
Series A1 0,000,000 00.000000 00.0 00 00 00 00 000
To view this company’s complete Cap Table, request access »

Recardio Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
build! Startups Corporation Minority 000 0000 000000 0
Carinthian Economic Promotion Fund Other Minority 000 0000 000000 0
Forschungsförderungsfonds Government Minority 000 0000 000000 0
Austria Wirtschaftsservice Other Minority 000 0000 000000 0

Recardio Executive Team (4)

Name Title Board
Seat
Contact
Info
Harald Kattnig Vice President of Information Systems & Managing Director, Austria
Darrell Nix Ph.D Chief Scientific Officer & Head of US Operations
Roman Schenk Founder & Executive Chairman
Klaus Dembowsky MD Chief Medical Officer, Europe

Recardio Board Members (1)

Name Representing Role Since Contact
Info
Roman Schenk Recardio Founder & Executive Chairman 000 0000